Practical management of pleural effusions: When and how should fluid accumulations be drained?

Postgraduate Medicine

Volumn 105, Issue 7, 1999, Pages 67-77

  Colice, Gene L ^a   Rubins, Jeffrey B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; DOXYCYCLINE; FIBRINOLYTIC AGENT; LIDOCAINE; MEPACRINE; PLASMINOGEN ACTIVATOR; STREPTOKINASE; TALC; TETRACYCLINE; UROKINASE;

ALGORITHM; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC APPROACH ROUTE; DIAPHRAGM PARALYSIS; DISEASE COURSE; DRUG INDUCED DISEASE; DYSPNEA; FIBRINOLYTIC THERAPY; HUMAN; LUNG EDEMA; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; REVIEW; THORACOCENTESIS; THORACOTOMY; THORAX DRAINAGE; THORAX RADIOGRAPHY;

EID: 0033057835     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.06.623     Document Type: Review

References (27)

1. Rubins JB, Colice GL. Evaluating pleural effusions. Postgrad Med 1999;105(5):39-42, 45-8
2. Agusti AG, Cardus J, Roca J, et al. Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis. Am J Respir Crit Care Med 1997;156 (4 Pt 1):1205-9
3. Estenne M, Yernault JC, De Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusioris. Am J Med 1983;74(5):813-9.
4. Dimopoulou I, Daganou M, Dafni U, et al. Phrenic nerve dysfunction after cardiac operations: electrophysiologic evaluation of risk factors. Chest 1998;113(1):8-14
5. Heffner JE, McDonald J, Barbìerì C, et al. Management of parapneumunic effusions: an analysis of physician practice patterns. Arch Surg 1995;130(4):433-8
6. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148(3):813-7
7. Sokolowski JW Jr, Burgher LW, Jones FL Jr, et al. Guidelines for thoracentesis and needle biopsy of the pleura. Am Rev Respir Dis 1989;140(1):257-8
8. Light RW, Jenkinson SG, Minh VD, et al. Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis, Am Rev Respir Dis 1980;121(5):799-804
9. Doyle JJ, Hnatiuk OW, Torrington KG, et al. Necessity of routine chest roentgenography after thoracentesis. Ann Intern Med 1996;124(9):816-20
10. Raptopoulos V, Davis LM, Lee G, et al. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol 1991;156(5): 317-20
11. Bartter T, Mayo PD, Pratter MR, et al. Lower risk and higher yield for thoracentesis when performed by experienced opeators. Chest 1993;103(6):1873-6
12. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980;69(4):507-12
13. Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med 1995;151(6): 1700-8 [Erratum, Am J Respir Crit Care Med 1995;152(2):823]
14. Himelman RB, Callen PW. The prognostic value of loculations in parapneumonic pleural effusions. Chest 1986;90(6): 852-6
15. Berger HA, Morganroth ML. Immediate drainage is not required for all patients with complicated parapneumonic effusions. Chest 1990;97(3):731-5
16. Stark DD, Federle MP, Goodman PC. CT and radiographic assessment of tube thoracostomy. AJR Am J Roentgenol 1983;141(2):253-8
17. Wait MA, Sharma S, Hohn J, et al. A randomized trial of empyema therapy. Chest 1997;111(6):1548-51
18. Swain JA. Empyema: an update on diagnosis and management. Puim Perspect 1991;8:6-8
19. Strange C, Sahn SA. The clinician's perspective on parapneumonic effusions and empyema. Chest 1993;103(1):259-61
20. Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Ann intern Med 1988;108(3):345-9
21. Betani CP, Pajeau TS, Bennett CL. Treating malignant pleural effusions cost consciously. Chest 1998;113(1 Suppl): 78-855
22. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120(1):56-64
23. Vargas FS, Teixeira LR, Coelho IJ, et al. Distribution of pleural injectate: effect of volume of injectate and animal rotation. Chest 1994;106(4):1246-9
24. Dryzer SR, Allen ML, Strange C, et al. A comparison of rotation and non-rotation in tetracycline pleurodesis. Chest 1993;104(6):1763-6
25. Lorch DG, Gordon L, Wooten S, et al. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 1968;93(3):527-9
26. Sherman S, Ravikrishnan KP, Patel AS, et al. Optimum anesthesia with intrapleural lidocaine during chemical pleurodesis with tetracycline. Chest 1988;93(3): 533-6
27. Alberts WM, Salem AJ, Solomon DA, et al. Hepatic hydrothorax: cause and management. Arch Intern Med 1991; 151(12):2383-8